Introduction: The analgesic efficacy of slow release tramadol in the titration phase of treatment of moderate to severe cancer pain has been demonstrated in clinical trials.
Objective: The aim of the study was to evaluate this treatment strategy in routine daily practice.
Method: This was a prospective, non-randomized, open, multicentric, phase IV two-week study.